| Without previous CVD | With previous CVD | All patients |
---|---|---|---|
n | 93,522 | 11,955 | 105,477 |
Malea | 50,963 (55) | 7,609 (64) | 58,572 (56) |
Age at diagnosis (years)b | 60 (13) | 68 (11) | 61 (13) |
Patients by year of diagnosisa | |||
 1990–December 1999 | 1,893 (2) | 201 (2) | 2,094 (2) |
 January 2000–December 2004 | 28,551 (31) | 3,741 (31) | 32,292 (31) |
 January 2005–December 2009 | 52,317 (56) | 6,647 (56) | 58,964 (56) |
 January 2010 | 10,761 (12) | 1,366 (11) | 12,127 (12) |
Smoking statusa | |||
 Current smoking | 17,545 (19) | 2,022 (17) | 19,567 (19) |
 Ex-smoking | 39,016 (42) | 6,922 (58) | 45,938 (44) |
BMI at diagnosis (kg/m2)b | 32 (7) | 31 (6) | 32 (7) |
HbA1c at diagnosis (%)b | 8.2 (2.2) | 7.8 (2.0) | 8.1 (2.2) |
HbA1c at diagnosis (mmol/mol)b | 66 | 62 | 65 |
HbA1C ≥7% (≥53 mmol/mol) post diagnosisa | |||
 Consistently during 1 year post diagnosis | 27,375 (29) | 3,096 (26) | 30,471 (29) |
 Consistently during 2 years post diagnosis | 20,856 (22) | 2,245 (19) | 23,101 (22) |
CVE during follow-upa | |||
 MI | 1,876 (2.01) | 569 (4.76) | 2,445 (2.32) |
 HF | 2,295 (2.45) | 898 (7.51) | 3,193 (3.03) |
 Stroke | 1,782 (1.91) | 485 (4.06) | 2,267 (2.15) |
 Any CVE | 4,293 (6.64) | 1,833 (8.39) | 6,126 (7.08) |
Renal diseasea | |||
 Before diagnosis | 16,630 (17.78) | 3,116 (26.06) | 19,746 (18.72) |
 Post diagnosis | 25,662 (27.44) | 4,601 (38.49) | 30,263 (28.69) |
Duration of follow-up (years)c | 5.0 (3.4, 7.2) | 5.4 (3.5, 7.7) | 5.3 (3.5, 7.7) |
Medicationa | |||
 2 OADs | 41,696 (45) | 4,515 (38) | 46,211 (44) |
 Insulin | 8,778 (9) | 1,004 (8) | 9,782 (9) |
 OAD + insulin | 8,380 (9) | 954 (8) | 9,334 (9) |
 Intensified treatment | 44,042 (45) | 4,012 (56) | 48,036 (46) |